Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CA12 mRNA | affects expression | 20382639
|
C006780 |
bisphenol A |
bisphenol A affects the expression of CA12 mRNA | affects expression | 20170705
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of CA12 mRNA | increases expression | 16474171
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in increased expression of CA12 mRNA | increases expression | 17720352
|
D003520 |
Cyclophosphamide |
CA12 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CA12 mRNA | increases expression | 20106945
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of CA12 mRNA | increases expression | 14996990
|
D004317 |
Doxorubicin |
CA12 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D004958 |
Estradiol |
Estradiol affects the expression of CA12 mRNA | affects expression | 14699072
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CA12 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of CA12 mRNA | increases expression | 16474171 15223131 19619570 15913882
|
D005472 |
Fluorouracil |
CA12 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D019833 |
Genistein |
Genistein results in increased expression of CA12 mRNA | increases expression | 16474171
|
C071834 |
glycidamide |
glycidamide results in decreased expression of CA12 mRNA | decreases expression | 17822822
|
D017239 |
Paclitaxel |
CA12 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CA12 mRNA | affects binding|increases activity|increases expression | 19710929
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in increased expression of CA12 mRNA | increases expression | 16474171
|
D020849 |
Raloxifene |
Raloxifene affects the expression of CA12 mRNA | affects expression | 14699072
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR1 protein] results in increased expression of CA12 mRNA | affects cotreatment|increases expression | 19059307
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of CA12 mRNA | affects cotreatment|decreases expression | 19059307
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of CA12 mRNA | affects expression | 14699072
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR1 protein] results in increased expression of CA12 mRNA | affects cotreatment|increases expression | 19059307
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of CA12 mRNA | affects cotreatment|decreases expression | 19059307
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CA12 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CA12 mRNA | increases expression | 20106945 19619570
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.55 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.84 | 15322242 14514962 11752688 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.10 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
10.18 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
10.18 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
10.18 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
10.18 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.87 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.87 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
11.41 | 21441931 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
11.41 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.54 | 15800139 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.62 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.62 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.58 | 15014928 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.71 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.71 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.79 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.75 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.70 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.55 | 15867366 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.84 | 11985600 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.46 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.79 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
9.74 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
9.74 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
9.74 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
9.74 | 16978400 11325840 15136595 18234424 17020986 12006526 18323546 17388661 15093573 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
9.74 | 15692762 16096432 15993339 19526202 15634643 18628466 18234424 15136595 15567936 11325840 17426702 15668708 16322301 17369602 16935488 17983394 16826403 16115903 16595493 18382427 18695136 15939500 15994142 16264153 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
9.74 | 14630087 19861407 17289903 16675129 17261762 12948864 17018787 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
9.74 | 15136595 16595493 16557594 18357371 16110121 19217205 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
9.74 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
9.74 | 16273361 18323546 15136595 16115903 16244791 11325840 18223236 18234424 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
9.74 | 17893378 15758505 15572757 16912660 15775269 17242785 17261762 17049068 17952589 17595753 17440819 16837676 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
9.74 | 19189212 18984771 19189210 19142967 19410462 19103187 21138602 16202921 19084267 18855134 20390343 19155303 19288272 18351453 19011961 11161223 18815881 15565566 17893378 19289846 19221464 20544844 17261762 18425577 17242785 19115204 19244106 18629630 16818667 15668708 20859285 20005174 17049068 20135344 19066611 19487384 20065188 18997820 18821012 21152245 16873071 16273361 19200415 17440819 19059307 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
9.74 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.45 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
12.35 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
12.35 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.13 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.13 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.49 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
14.06 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
14.06 | 16023760 16234567 18059187 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
14.06 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
14.06 | 17088986 16799960 17045692 18930000 16332177 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
14.06 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
14.06 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
14.06 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.98 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.88 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
10.84 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
10.84 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
10.84 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
7.62 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.62 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.62 | 16280240 17066447 16757204 18986760 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.44 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.44 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.35 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.51 | 17382496 17007740 15811867 16242529 18627295 15476868 15792986 17308081 16731534 17329180 16651473 16269455 16455267 15505089 17928571 17351982 17974986 17131338 16952015 16364871 16278810 16109756 16612575 17519947 17924179 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.94 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
7.45 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
7.45 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.05 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.05 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.05 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.14 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.70 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.70 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.09 | 15668235 15340226 16354765 12621046 8697196 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.60 | 15800139 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.84 | 17287894 17018589 17172411 17016597 16340194 17169374 16510598 17725105 15001691 18772588 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.84 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.86 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
4.86 | 17695437 18949393 17401013 17094418 16331619 17594712 16524972 18383874 16282729 17255274 15148649 15289873 18448328 17454858 20501625 18288408 18802399 16303861 16391804 17016601 14970324 18509181 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
4.86 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
4.86 | 15531428 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.04 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 20055451 15322242 10048152 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.99 | 16989017 18093676 18710439 11948286 16651033 15276878 17010015 10498854 12161096 16614059 12388444 18295254 12913760 18483878 10700343 18372110 18433785 15643279 16413132 17979934 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.78 | 16733453 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.68 | 16140633 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.35 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.14 | 17474826 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.41 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.05 | 15331540 11751995 10990075 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.21 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.31 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.31 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
14.92 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
14.92 | 17451421 15920148 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
14.92 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
3.85 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.85 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.06 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.06 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
11.32 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
11.32 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.32 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.90 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
15.37 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
15.37 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
15.37 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.58 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
17.69 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
17.69 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
17.69 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
17.69 | 16202921 17893378 20544844 19155303 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.00 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.16 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.20 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.32 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
7.32 | 16785472 16481741 15173087 17638652 16337965 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
7.32 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.63 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.63 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
18.63 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
18.63 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.22 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.44 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.52 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
11.41 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
11.41 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.44 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.44 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.21 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.29 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.29 | 16598420 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.86 | 16145905 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.51 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.59 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.02 | 11014644 15172196 16376943 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.87 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.87 | 18337622 15102660 15162350 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.32 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
7.79 | 16244372 14766674 17875725 16144979 16330681 16495754 16707910 12587719 18674790 17888722 18006777 16879835 16244371 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
7.79 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.01 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.01 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.88 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.41 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.28 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.32 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.53 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.22 | 18467677 19772884 19176532 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.22 | 12621046 16120746 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.03 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
7.65 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
7.65 | 18501091 17606976 15147373 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.75 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.05 | 16959395 16354765 8697196 18606429 15340226 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.16 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.54 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.54 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.54 | 18670907 18850075 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.33 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.61 | 7193160 16517039 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.85 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.85 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
12.24 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
12.24 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.24 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.32 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.44 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.02 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
10.02 | 15699352 15369732 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
10.02 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.13 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
17.62 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
17.62 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
17.62 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
17.62 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.48 | 16973256 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
6.64 | 10602166 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.64 | 18980019 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.16 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.49 | 18587576 17802794 17658394 17008537 17296974 18172266 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.07 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.96 | 11830472 10052129 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.14 | 15342952 17567588 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.80 | 17353645 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
8.72 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.72 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
8.72 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
8.72 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.72 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.72 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
10.62 | 18383874 17045692 15113037 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.62 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
10.62 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.62 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.90 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
9.90 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.90 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.84 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
4.84 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.84 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.84 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.78 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
7.83 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.83 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.58 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
14.57 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
14.57 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
14.57 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.55 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.75 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
14.18 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
14.18 | 11807958 16891317 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
14.18 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
14.18 | 19196723 19196722 16827153 14580682 11731420 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.65 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.65 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
5.20 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
5.20 | 16342250 12040289 12025231 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.20 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.17 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.79 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.05 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.79 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.48 | 15792986 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.55 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.61 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.78 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
7.57 | 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
7.57 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.49 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.44 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
9.44 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
9.44 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.00 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
14.08 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
14.08 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
14.08 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.55 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.57 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
9.57 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
9.57 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.51 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
8.29 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
8.29 | 16928823 18600527 18239605 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.29 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.00 | 19189210 19200415 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.72 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.75 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.44 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.23 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.23 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
23.33 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
23.33 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
23.33 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
23.33 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
7.18 | 16115947 8761367 15176712 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.18 | 15555623 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.88 | 8761367 12837982 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.42 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.31 | 8291058 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.81 | 20558911 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.70 | 16517039 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.97 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
7.29 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
7.29 | 17882678 19059307 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
10.08 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
10.08 | 15579764 15758505 17893378 17823083 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.09 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.98 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.95 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
7.95 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
7.95 | 11161223 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.61 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
5.58 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.58 | 16929163 16500647 15113037 19003803 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
3.38 | 16702228 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.25 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.16 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.16 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.54 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.20 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.79 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.48 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.48 | 11118676 11399792 11896295 11222880 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.77 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.49 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.49 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
4.28 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
4.28 | 15754350 12479363 18247401 16644109 16289102 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
4.28 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
4.28 | 15749863 16729912 16868541 18437689 16888761 15897917 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
4.28 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
4.28 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
4.28 | 15256057 16925846 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
4.28 | 16356831 17136230 17172428 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
4.28 | 15721890 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
4.28 | 15731164 16220300 16536755 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
4.28 | 15067354 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.22 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.78 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.27 | 16636934 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.55 | 15770314 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.99 | 18722050 15538739 18286688 16160472 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.21 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.38 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 18990726 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.97 | 17710206 16767912 15675481 17203757 18313854 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.23 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.78 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.80 | 16636934 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.65 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.65 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.55 | 15625365 16767912 17203757 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.29 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.51 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.03 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.74 | 19015929 16424979 16951190 18396642 18567086 17172411 19084572 17522103 17498489 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
2.74 | 18396642 18506536 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.80 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.97 | 16045194 16684133 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.05 | 12837982 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.80 | 16930453 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.90 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.35 | 16010429 17909728 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
13.71 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
13.71 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.97 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
15.77 | 15537745 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
15.77 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
15.77 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
15.77 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
15.77 | 8653321 17572228 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.86 | 16803524 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.01 | 14652134 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.98 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.59 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.21 | 16837676 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.21 | 17638931 17334414 16364871 17678736 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.55 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.25 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.44 | 17120751 |